Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8481039
APP PUB NO 20120177649A1
SERIAL NO

13365769

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Medicaments for treating diseases related to HB-EGF escalation are in demand. The present invention provides a monoclonal antibody or an antibody fragment thereof which binds to a cell membrane-bound HB-EGF, a membrane type HB-EGF and a secretory HB-EGF.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
KYOWA HAKKO KIRIN CO LTDTOKYO 100-8185

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ando, Hiroshi Tokyo, JP 180 2805
Furuya, Akiko Tokyo, JP 56 565
Iwamoto, Ryo Osaka, JP 7 13
Masuda, Kazuhiro Tokyo, JP 32 277
Mekada, Eisuke Osaka, JP 11 28
Miyamoto, Shingo Fukuoka, JP 34 105
Nakamura, Kazuyasu Tokyo, JP 84 2624
Sasaki, Yuka Tokyo, JP 20 152
Shitara, Kenya Tokyo, JP 83 2179
Takahashi, Kumiko Cambridge, US 12 49

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 9, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00